Anteris Technologies (Nasdaq:AVR) had first patients enrolled and successfully treated in a global pivotal trial of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results